1. Generics Bulletin

Pfenex And Alvogen Launch US Teriparatide

First Pfenex Launch Comes As Firm Waits For Equivalence Designation

 
• By Dave Wallace

Pfenex marketing partner Alvogen has introduced the firm’s Bonsity version of teriparatide in the US. Representing the first Pfenex-developed product to hit the market, the launch comes as the companies are still awaiting a formal equivalence designation from the FDA.

Debut
Pfenex is making its debut in the US with teriparatide • Source: Shutterstock

Pfenex and marketing partner Alvogen have launched the firm’s PF708 version of teriparatide in the US.

“We are pleased to announce the availability of teriparatide injection in pharmacies, the first new US Food and Drug Administration-approved...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Products

More from Generics Bulletin